Immune support

Probiotics: fewer infections

Immune calming + barrier

Gut barrier - intestinal permeability

Immune defense - infections -20%

Immune↑ Tregs

Inflammation↓ IL-6

infection↓ 44%

Immune markers +13%

+T cells 12%

Immune boost, fewer infections

Immune suppression, fewer flares

Immune support: -85% infection

Immune support: -13% sores

Inflammation↓, EPA↑

Complications↓, infections↓

Bifido+SCFA, ↓inflammation

Fewer infections, better immunity

Higher immunity +30-90%

More reactogenicity

Boosted immune cells

Reduced inflammation/oxidation

Inflammation↓ IL-6/TNF

Infections↓, vaccine↑

Immune support:+54% seroconversion

Immune support:fewer infections

Lower inflammation, more n‑3

Immune function shifts

Allergy/immune tolerance

+46.6% GSH

Lower IL-6; anti-inflammatory

+70% C, better immunity

Immune markers + infections

T-cell support + less infection

Inflammation down, immunity up

Immune recovery +26.7%

Infections down 26%

T-cell markers up

Milk antibodies, cytokines

Immune transfer, ±10%

Mucosal IgA, +79%

Immune cells↑, infections↓

CRP↓, arginine↑

HIV/CD4: +2.24 risk

Less malaria/anemia: −69%

Immune cells/cytokines: faster clearance

Butyrate↑ immune markers

LPS/inflammation↓ butyrate↑

Lower LTB4/LTE4

AA→EPA/DHA shift

Immune support +14%

GSH↑, immune function

Oxidative/inflammation↓, infections↓

Inflammation↓ immune support

Treg/antioxidant↑ immune support

Immune cells +151

Infections −30%

Immune support, fewer infections

Immune support, faster recovery

GSH↑, immune survival

Inflammation↓, outcomes↑

Anti-inflammatory, gut SCFA

Vaccine antibodies, +10–80%

Immune boost: IgA, T-cells

+35% NK/Phagocytosis

Inflammation down, immunity up

Sepsis/NEC ↓ 46%

Sore throat/cold ↓ 68%

Fewer infections, shorter illness

Lower inflammation, better immunity

↓炎症/免疫 markers

↓airway/respiratory immune reactivity

Inflammation↓, immunity↑

Mortality↓, immunity↑

T-cell boost

WBC increase

Cytokine balance

Inflammation/oxidative stress ↓

Antiviral/immune response ↑

Infection outcomes ↓

Antibody/T cell boost

Rhinitis/asthma relief

Immune recovery + complications

Infections ↓, HLA-DR/TNF-α ↑

Respiratory/infection ↓

Inflammation/immune ↑

ALT/AST, immune↑

Infections, immune defense↓

T-cells, response↑

Immune markers −65%

Inflammation/cytokines reduced

Lower copper, weaker immunity

Fewer infections, better wounds

↑Immune markers with copper

Immune/infection ↓, +5‑fold folate

Inflammation ↓, homocysteine −22%

Neutropenia ↓, WBC +

NK/T cells +43%

Respiratory infections -45%

Basophils -65%

Nasal symptoms -p

Inflammation markers -p

Immune activation +

Inflammation -59% IL-1β

Catheter infections 0 cases

WBC/CRP improvement

Gut barrier/endotoxin ↓

Inflammation markers ↓

Antiviral immunity +20–70%

Warriors, less infections

Gut barrier, microbiota

Inflammation/antiviral boost

Immune cells/antibodies

Lower inflammation

Boosts immune regulation

Leukocyte/antibody boosts

−55% anti‑TPO

−34pp mucositis

Immune markers + B12

Inflammation ↓, antibodies ↑

Immune boost, infections ↓

Cytokines/ALT, +23% remission

Immune cells + pathogens

Cold infections ↓41-58%

NK/cytokines ↑

Infections/colds ↓

Allergy symptom relief

CD4/viral load support

Inflammation down, IL-10 up

Myoglobin down, immune balance

Immune markers +

Gum inflammation ↓

Infection/inflammation ↓

Inflammation down

Endotoxin/immune markers down

Blood pressure down

Skin improvement, ~50%

T-cell shift, no morphology

DLQI -5.9, PASI75 37.5%

Inflammation down, IL-1β/IL-6

CRP/ESR down, TNF-α

Allergy symptoms/IgE

Crohn’s inflammation/remission

Inflammation/oxidative stress ↓

Mucosal/immune protection ↑

Oxidative stress -65%

Inflammation/infection ↓

Inflammation ↓; IL-4/IL-6

Immune balance ↑; IFN-γ

Fewer infections, +antibodies

Immune activation, +IgA/IgG

Omega‑3↑; inflammation↓

Liver markers stable

Inflammation↓, IFN-γ

Oxidative stress↓, 8-isoprostane

Immune cells↑, IL-10

Fewer infections, shorter duration

Lower inflammation, better immunity

NK activity ↑

Inflammation ↓

Inflammation genes ↓

Glucose/IL-6 ↓

Immune activation+antibodies

Inflammation down

T-cell suppression

Reduced inflammation

Immune marker gains

Immune shifts, modestly ↑

MBL/activity changes, risk

Proline/arginine ↑; immunity +

Antibodies ↑; inflammation ↓

Immune markers +10%

Immune suppression -5

Ornithine ↑; lymphocytes ↑

Infections ↓; stay ↓

Immune markers ↑

Antibody boost +8.08

Cold/tonsillitis fewer cases

↓ Salmonella 2–4 log

↑ immune organs/lymphocytes

Immune cells up

Viral reactivation down

CD4+ 60%→37.5%

Anti-inflammatory, antioxidant support

+oocyte outcomes

Cytokines/oxidative stress -

Innate immunity ↑ (NK +34%)

Post-transplant infections ↓ (−10.8%)

UTI defense −51%

Immune cell boost

Lower sting reactions -8%

Higher tolerance markers

Immune recovery

-50% ARDS

Inflammation↓, immunity↑

Flu protection↑ 73%

Immune markers +

Inflammation down, immunity up

Immune markers +

Inflammation −

Amino acids + serine

Immune markers +29%

Immune cells + response

+41% tumor response

Antibody/platelet support

Faster URI recovery

Immune markers ↑

HDL up, CRP -15%

Triglycerides -15%, Lp-PLA2 -20%

UV immune protection

↓ IL-8, ↑NAD+

T-cell shifts

Fatigue relief

Lower inflammation; -60%

Boosted antiviral response; +38%

↓Inflammation markers

↑Immune cells

Anti-inflammatory genes

−IL-1/TNF-α

Immune/allergy relief

Allergy relief, IgE ↓100

Inflammation control, CRP/ESR ↓

Lymphocytes, +8.9 kg

NK/IL-6, +34.1%

Warts, +11.9 pp

Immune markers −27.9%

Symptoms, inflammation ↓

Inflammation ↓; O2sat +4.8

Immune/eradication ↑; +9.0

Throat/nasal relief +53%

Overall symptoms improved 2.1x

Earache/runny nose reduced

Immune illness↓

Infections↓ 29-38%

Fewer infections, shorter illness

Better autonomic, viral markers

Inflammation, CRP −59%

UTI risk −55%

Antibody boost +8.08

Cold incidence -

Tetanus IgG +

Cough ↓, recovery faster

NK, IgG/IgA/IgM ↑

Immune recovery +28%

Inflammation/allergy −1.7d

Lower inflammation

Better immune markers

↓ T-cell activation

↑ IgA/IgM; ↓ cytokines

Omega-3↑, immune cells↑

Disease activity↓, +3.6% Omega-3

Inflammation -IL-6, TNF-α

Antibacterial support -streptococci

Immune signaling + cells

NLR -reduced

Immune markers down

IL-8 −52.6%

Cytokines down

HPV clearance +14.4%

Inflammation/SpO2 +4.6%

Cu/Se raise immunity

Hepcidin +1.5x, DMT1↓

JAK/STAT ↓; autophagy ↓

Viral clearance ↑; CD4 recovery ↑

Symptoms ↓

IL-6 -55.5%

Lower inflammation

better cytokine balance

Immune markers ↓, +50% TGF-β1

MDRO/AMR burden ↓, A. muciniphila

Symptoms improved, no safety issues

Inflammation ↓; IL-6/8/TNF-α

Immune illness ↓; 28%

Leukopenia response +85%

Rescue use -3.09

↓ inflammation, ↑ microbes

↓ plaque/bleeding, pathogens

Immune markers improved

EDSS better, PUFAs

TNF-α/MDA ↓

Cytokines shifted

RBC preserved

QoL, ABU +26%

Hospital stay −0.95d

Immune modulation: IFN-γ

Inflammation relief: −3.29 SCCAI

DNA damage -40%

T-cells/carotenoids +30%

↓oral pathogens, acid

↓IL-17A (~4.4x)

Inflammation/oxidative stress ↓

IL-6, IFN-γ ↓

No lipid/glucose change

Immune marker up

Respiratory events -29.6%

Immune signalling −43%

Allergic activation −65%

Reduced airway inflammation

Better asthma control

Symptoms -57%

IgE/IgG4 shift

IL-1ra/5/7 ↑

IgE & symptoms ↓

H. pylori, inflammation

NK granzyme B +

HPV clearance 88%

T-cell shifts

Milk +3.3 kg/day

Immune markers ↑

Antibody/PBMC/IFN-γ ↑

Mortality/rehospitalization ↓13.3%

Shorter stay +86%

NK + IFN-γ boost

hsCRP −8.4%

Sore throat relief, 81.6% responders

Earlier antipyretic stop, faster recovery

CD4 +84 cells/µL

No VL or weight change

COVID-19 risk -55%

Mild side effects

TgAb down -46.2

More side effects +37%

NK activity +12%

IFN-γ +1.7 pg/mL

↓ inflammatory markers

↓ TG/VLDL

Anti-inflammatory oxylipins +

Lower IL-6/IL-8

Skin lesions improved

S. aureus inhibited

Blood pressure −9.67 mmHg

Inflammation marker −1.03 mg/L

Triglycerides −14.22 mg/dL

Endotoxin/MMP-9/IL-18 ↓

Response rate +21.6%

Clearance +21–40%

T/NK + cytokines

Clearance +20%

Cytokines, T-cells up

Function +0.105; activity

Physician/RAQoL/SF-12 improved

Immune vigor, CD4+ T cells

Total/naïve T cells increased

Oral hygiene +0.7

Periodontal scores -1.0

Anti-inflammatory −21% CRP

Oxidative defense +Nrf2

Giardia cleared 100%

Symptoms improved

Relapse/lesion reduction

EDSS/MSFC improved

SNOT-22 -11.6 points

Endoscopic improvement

Vitamin A, antibodies +68%

+128% response, 0% weak

↑beta-cell, ↓IFN-γ

↓insulin dose, ↑IL-4

IL‑1β ↓; symptom relief

No eradication effect

Urticaria - lower UAS7

Quality/sleep better

Acute phase −2 days

Recovery QoL, mental

CRP down; CD4 up

IL-1α/β up

WBC/neutrophils drop less

-13.4% vs -31.5%

T cells unchanged

Inflammation -30–66%

Blood pressure/LDL -8%

SIgA +41%/+37%

NK/Th1 cytokines increased

UroA/butyrate↑ CRP↓

Naive CD8↑ metabolism shift

Immune cells shifted +

Bile acids increased

Inflammation -59%

DNA protection ~90%

UTI recurrence -70%

Urgency/incontinence improved

↓IL-6/hs-CRP; ↑TAC

Immune support improved

Mo/Cd damage

Cu boosts antibodies

Mixed immune markers

Non-monotonic dose response

Anti-inflammatory IL-10 +2.2

Glucose control -5.8

Mood maintained; inflammation ↓

BDNF ↓ dose-dependent

Lower inflammation markers

Fibrinogen down

↓TNF-α, neopterin

↑IFNγ/IL-4

T-cells +0.24

Bifidobacterium +29%

Immune age -2y